Please ensure Javascript is enabled for purposes of website accessibility

Will Medtronic Beat These Analyst Estimates?

By Seth Jayson - Updated Apr 10, 2017 at 1:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Checking expectations

Medtronic (NYSE: MDT) is expected to report Q4 earnings on May 21. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Medtronic's revenues will increase 2.1% and EPS will grow 4.0%.

The average estimate for revenue is $4.39 billion. On the bottom line, the average EPS estimate is $1.03.

Revenue details
Last quarter, Medtronic logged revenue of $4.03 billion. GAAP reported sales were 2.8% higher than the prior-year quarter's $3.92 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.93. GAAP EPS of $0.97 for Q3 were 10% higher than the prior-year quarter's $0.88 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 75.2%, 100 basis points worse than the prior-year quarter. Operating margin was 28.2%, 70 basis points worse than the prior-year quarter. Net margin was 24.5%, 60 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $16.52 billion. The average EPS estimate is $3.69.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,711 members out of 1,804 rating the stock outperform, and 93 members rating it underperform. Among 496 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 481 give Medtronic a green thumbs-up, and 15 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Medtronic is outperform, with an average price target of $46.71.

Is Medtronic the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Medtronic plc Stock Quote
Medtronic plc
MDT
$90.80 (0.64%) $0.57

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.